Blanket Purchase Agreement FA301623A0001
Award Date
10/17/22
Last Date to Order
10/16/27
Federal Agency
Air Education and Training Command
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This single-award Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $7,167,141 BPA, with a period of performance through November 30, 2029, is for the procurement of ROCHE MICRO BPA REAGENTS, KITS AND CONSUMABLES to support the U.S. Air Force School of Aerospace Medicine (USAFSAM). This BPA...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation to provide reagents, kits, and consumables for immunochemistry and clinical chemistry testing. The 5-year, $37 million BPA will enable DHA, which includes the U.S. Air Force School of Aerospace Medicine (USAFSAM), to acquire these critical laboratory supplies as needed to support healthcare services for veterans, active duty military personnel, dependents, retirees, and...
The Blanket Purchase Agreement (BPA) contract FA301625A0005 was awarded to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The single-award, $4,500,000 BPA was issued by the Air Education and Training Command, a Defense agency, with a period of performance from October 1, 2024 to May 1, 2027. The BPA is intended to provide the agency with streamlined access to a variety of Roche's...
This series of Blanket Purchase Agreement (BPA) awards to Roche Diagnostics Corporation provide the U.S. Department of Defense's Defense Health Agency (DHA) and Air Force Life Cycle Management Center (AFLCMC) with critical medical equipment, reagents, and consumables to support laboratory operations at military treatment facilities and the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory. The BPA awards, issued against Roche's existing General Services Administration...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The BPA and associated task orders provide the USAFSAM Epidemiology Laboratory with Roche's COVID-19 testing equipment, including automated molecular testing platforms, as well as associated kits, reagents, and...
The Department of the Army Medical Command awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation on July 22, 2022. The potential value of the BPA is $625,000 for the procurement of reagents and supplies with an ordering period through July 21, 2023. Roche Diagnostics Corporation will provide reagents and supplies to support the Department of the Army Medical Command's medical operations under the BPA. As the prime contractor, Roche will supply products to various...
This is a 5-year Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The BPA, with a total ceiling value of $80,000, provides the VA with Influenza A/B and Strep A test kits and quality control reagents for Roche's Cobas Liat equipment. Roche Diagnostics will...
The Defense Health Agency awarded a blanket purchase agreement to Roche Diagnostics Corporation with a potential value of $20 million. The BPA will facilitate orders for COVID-19 test kits and medical supplies to support the Agency's testing, research, and healthcare programs. Task orders issued against the BPA indicate Roche will provide reagents, test kits, consumables, diagnostic equipment, and laboratory supplies from its facilities in Bethesda, Maryland and Castleton, Indiana. Orders...
The Blanket Purchase Agreement (BPA) with Roche Diagnostics Corporation, valued at $3,180,000.00, was awarded by the Defense Health Agency, a defense agency, to provide a variety of medical laboratory products and services over a period of 5 years with a completion date of October 16, 2027. The BPA allows the agency to acquire chemistry and immunochemistry laboratory testing, including critical care analyzers, reagents, test kits, and associated equipment, supplies, and services on an...
Roche Diagnostics Corporation has been awarded a single award blanket purchase agreement by the Defense Health Agency to provide laboratory testing reagents and a cell stainer. The potential value of the BPA is $129,021.70 through April 2024. A firm fixed price call was placed against the BPA for $15,314.77 to supply reagents supporting DHA programs. The reagents will be delivered to a facility in Castleton, Indiana with performance through September 2023. As the prime contractor, Roche...